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Abstract
Background: The aim of this study was to analyze the cell-specific expression of E- and N-cadherin and b-catenin
in developing human lung tissues from 12 to 40 weeks of gestation.
Methods: Fortyseven cases of developing human lung including pseudoglandular, canalicular, saccular and alveolar
periods were analyzed by immunohistochemisty for E- and N-cadherin and b-catenin and twentyone cases were
also investigated by RT-PCR for E- and N-cadherin and b-catenin. For identifying the lung cells, the sections were
also stained with antibodies against thyroid transcription factor-1 (TTF-1) and caveolin-1. Normal adult lung tissue
was used as a control.
E-cadherin was strongly expressed in epithelium of bronchi and large bronchioles from week 12 onwards and it
was also positive in alveoli in pretype II cells and type II cells. N-cadherin was present in most of the epithelial cells
of bronchi and the largest bronchioles during the pseudo-glandular and canalicular periods. N-cadherin was not
detected in epithelium of developing alveoli. b-catenin was strongly membrane-bound and positively expressed in
bronchial epithelium from week 12 to week 40; it showed nuclear positivity in both developing airway epithelium
and in the cells underneath the epithelium during pseudo-glandular period and to a lesser degree also in the
canalicular period. b-catenin was positive in pretype II cells as well as in type I and type II pneumocytes within
alveoli.
RT-PCR analyses revealed detectable amounts of RNAs of E- and N-cadherin and b-catenin in all cases studied. The
amounts of RNAs were higher in early stages of gestation.
Conclusions: E-cadherin is widely expressed in bronchial and alveolar epithelial cells. N-cadherin exhibit extensive
epithelial positivity in bronchial epithelial cells during early lung development. The presence of b-catenin was
observed in several cell types with a distinct location in tissue and cells in various gestational stages, indicating
that it possesses several roles during lung development. The expressions of protein and mRNAs of E- and
N-cadherin and b-catenin were higher in early gestation compared to of the end. Moreover, the expressions of
these factors were higher during the lung development than in the adult human lung.
Background
There is still little detailed knowledge of how cells dif-
ferentiate during ontogenesis in the lung as well as in
pulmonary diseases. It has been assumed that signalling
processes occuring during pulmonary fibrosis and lung
cancer may share similarities with the various stages of
human lung development, thus by studying lung devel-
opment it might be possible to acquire valuable infor-
mation that may be useful when researching fibrotic and
neoplastic lung diseases [1]. The epithelial changes are
regulated by the extracellular matrix (ECM), which is an
essential element in the process of branching morpho-
genesis, and also participating in the control of cell phe-
notype expression. In our previous studies, we have
observed that the levels of several ECM proteins e.g.
tenascin-C and precursors of collagen I and III are
increased in certain localizations during human lung
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compared to the healthy adult normal lung [2-5].
Cells are connected with each other or the ECM in
different ways but it is clear that adhesion molecules are
extremely important in cellular junctions. The cadherins
represent an important subclass of adhesion molecules
[6]. The cytoplasmic domain of cadherins interacts with
catenins, and this complex associates with actin fila-
ments [7]. The cadherin superfamily consists of several
members and one of these, E-cadherin is expressed in
epithelial cells and it is nowadays a commonly used
marker of cell epithelial phenotype in studies focusing
on the epithelial-mesenchymal transition (EMT) [8].
N-cadherin was originally found to be expressed in
neural and muscle cells, but subsequently it is observed
be an element of mesenchymal cells [9]. In studies
investigating the EMT, N-cadherin has been used as a
marker of mesenchymal differentiation [8]. Specific cad-
herins have been shown to directly stimulate cellular
differentiation into certain types of tissue [10]. Recently,
expression of N-cadherin has been observed to be pre-
sent in epithelial lung tumors in addition of E-cadherin
and b-catenin [11].
b-catenin serves many roles in the maintenance of cell
architecture, for example it can bind to the cytoplasmic
tail of E-cadherin. The WNT/b-catenin signal transduc-
tion pathway has been shown to control embryonic
patterning [12]. The cell specific expression profile of E-
and N-cadherin during developing human lung is still
unclear, though the role of b-catenin in lung organogen-
esis has been evaluated more extensively [13]. A pre-
vious study indicated that b-catenin signalling was
required for the formation of the distal, but not the
proximal, airways, and that the excision of b-catenin in
epithelial cells caused respiratory failure and death [14].
The aim of the immunohistochemical study was
to examine the cell-specific expression of E- and
N-cadherin and b-catenin in normal human developing
lung at different gestational ages i.e. from week 12 to
week 40 during the pseudoglandular, canalicular, saccu-
lar and alveolar periods. We hypothesized that the
expression and localization of these factors could vary
during the different developmental periods. In addition
to protein localization by immunohistochemistry, the
amounts of RNAs were evaluated in some cases by
quantitative real-time reverse transcriptase polymerase
chain reaction (RT-PCR).
Methods
Patients and handling of specimens
Samples of lung tissue were retrieved from the files of
the Department of Pathology, Oulu University Hospital.
The study protocol was approved by the Ethical com-
mittee of the Northern Ostrobothnia Hospital District
(Stament 64/2001, amedment 68/2005). The National
Supervisory Authority for Welfare and Health (Valvira)
has given a license for this study for the use of lung tis-
sues of abortive foetuses for research purposes (Reg. nr.
7323/05.01.00.06/2009). Since this is a retrospective
material, the informed consent permission has been
given by the National Supervisory Authority for Welfare
and Health, which is the national licensing authority for
social welfare and health care (please see http://www.
valvira.fi/en/licensing).
The study material for developing lung consisted of
47 cases of spontaneous abortion, stillbirth, and autop-
sied infants who had died for different reasons without
lung disorders within 1-2 days after birth in Oulu Univer-
sity Hospital between 1990 and 2002. Autopsies had been
performed within one day in most cases and within two
days in four cases. Causes of death of the infants were
abortion (n = 19), abruption of placenta (n = 9), rupture
of fetal membranes (n = 2), feto-fetal transfusion (n = 2),
sacral teratoma (n = 2), prolapse or aplasia of the umbili-
cal artery (n = 3), placentitis or chorioamnionitis (n = 4),
hemochromatosis (n = 1), hydrocephalus (n = 1), menin-
gomyelocele (n = 1), encephalocele (n = 1), holoprosen-
cephaly (n = 1) and hemorrhage of caput (n = 1). Infants
with pneumonia, cardiac abnormalities or features of
maceration were excluded. The gestational ages of infants
ranged from 12 to 40 weeks, corresponding to the pseu-
doglandular (day 52 to week 16, 13 cases), canalicular
(weeks 16-28, 17 cases), saccular (weeks 28-36, 9 cases)
and alveolar (weeks 36-40, 8 cases) periods. Uninvolved
peripheral lung tissue from adults, used as a control, was
obtained from six patients operated on for benign lung
tumour. The clinical information was obtained from the
patient records.
Lung samples, which had been taken from different
parts of the left or right lung were fixed in 10% formalin
and then dehydrated and embedded in paraffin. Sec-
tions, which were 5 μm thick, were stained with hema-
toxylin-eosin. All material was re-evaluated, and one
representative tissue block from each case was selected
for the immunohistochemical studies. In order to iden-
tify the phenotype of the various lung cells, the sections
were also stained with antibodies against thyroid tran-
scription factor (TTF-1) (a staining for type II pneumo-
cytes) and caveolin-1 (a staining for type I pneumocytes)
and some selected cases also with vimentin (a staining
for fibroblast and myofibroblast).
Antibodies and immunohistochemical staining
E-cadherin antibody (clone HECD-1) and N-cadherin
antibody (clone 3B9) were purchased from Zymed
Laboratories Inc (South San Francisco, CA, USA).
b-catenin antibody (clone 5) was purchased from Trans-
duction Laboratories (Lexington, KY, USA), TTF-1
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1 (clone E249) from Abcam (Cambridge, UK) and
vimentin (clone V9) from DakoCytomatin (Glostrup,
Denmark). The sections were incubated overnight with
antibodies to E-cadherin (diluted as supplied 1: 300),
N-cadherin (diluted as supplied 1: 200), b-catenin
(diluted as supplied 1:200), vimentin (diluted as supplied
1:1500), TTF-1 (diluted as supplied 1:100) and caveolin-
1 (diluted as supplied 1:250). Immunohistochemistry
was performed using paraffin-embedded biopsies. Tissue
samples were sectioned and deparaffinized followed by
an antigen retrieval procedure suitable for the antibody
in question. Dako Envision Kit (Dako) was used in the
immunohistochemistry with a 30 min incubation for the
primary antibody. Negative controls were obtained by
substituting non-immune rabbit or mouse serum and
PBS for the primary antibodies.
Scoring of the immunoreactivity
The extent and intensity of E- and N-cadherin and
b-catenin were evaluated semiquantitatively as negative
(0), weak (+), moderate (++) or strong (+++) in differ-
ent types of pulmonary cells, such as epithelial cells of
bronchioles and bronchus, alveolar epithelium includ-
ing pretype II cells, type I and II pneumocytes,
endothelial cells, interstitial cells such as fibroblasts
and myofibroblasts, and mesothelial cells. In the eva-
luation, membrane-bound positivity, cytoplasmic and
nuclear positivity were quantified.
Quantitative real-time reverse transcriptase polymerase
chain reaction (RT-PCR)
In 21 cases representing all developmental periods (pseu-
doglandular, n = 4; canalicular, n = 8; saccular, n = 7;
alveolar, n = 4) one tissue block was selected for E-cad-
herin, N-cadherin and b-catenin analysis at the transcrip-
tional level by quantitative real-time reverse transcriptase
polymerase chain reaction (qRT-PCR) as previously
described [15]. Additionally five paraffin embedded sam-
ples of normal adult human lung were used as controls.
As it has been shown previously RNA can be isolated
from paraffin embedded tissue material for expression
profiling [16,17]. The total RNA was isolated from five 10
μm thick slices from each sample with Purelink FFPE
total RNA isolation kit according to the manufacturer’s
instructions (Invitrogen, C a r l s b a d ,C A ,U S A ) .T h ei s o -
lated RNA was quantified and qualified spectrophotome-
trically and 0.5 μg of isolated RNA was converted in
duplicate to cDNA by RevertAid first strand cDNA
synthesis kit (Fermentas, EU) by using random hexamers
as primers. Quantitative RT-PCR was performed by
using the iQ5 Optical system (Bio-Rad Laboratories, Her-
cules, CA) with SYBR Green I technology (iQ Custom
SYBR green supermix, Bio-Rad Laboratories). PCR was
performed in duplicate from each cDNA by using 66°C
as the annealing temperature. The primers were 5’-aaggt-
gacagagcctctggat-3’(forward, f) and 5’-cgtctgtggctgtgacct-
3’(reverse, r) for E cadherin; 5’-cgagccgcctgcgctgccac-3 (f)
and 5’-cgctgctctccgctccccgc-3 (r) for N-cadherin;
5’-tggatgggctgcctccaggtgac-3’ (f) and 5’-accagcccacccctc-
gagccc-3’(r) for b-catenin; and 5’-gagtcaacggatttggtcgt-3’
(f) and 5’-gacaagcttcccgttctcag-3’(r) for glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) that was considered
a sah o u s e - k e e p i n gg e n ei nt h ed a t aa n a l y s i s .T h er e s u l t s
were counted by the Livak ΔΔCt method using a sample
of normal adult lung as a reference [18]. Differences
between the groups were analysed by PASW Statistics
software version 17 (SPSS, Chicago, IL, USA) by using
Kruskal-Wallis test.
Results
Immunohistochemistry for E- and N-cadherin and
b-catenin
Pseudoglandular period (weeks 12 to 16)
E-cadherin was strongly expressed in all the epithelial
cells of developing bronchi and bronchioles of all sizes
including also the smallest structures (Figure 1A, 1B).
N-cadherin was also moderately or strongly expressed
in the epithelium of bronchi and largest bronchioles
whereas it was negative in the smallest developing airways
(Figure 1C, 1D). b-catenin displayed strong membrane-
bound positivity in bronchi and larger bronchioles,
whereas its expression in the small developing airways was
mainly strongly nuclear (Figure 1E, 1F, 1G). The cells
underneath the epithelium, especially in smallest airways,
showed also nuclear positivity for b-catenin (Figure 1G),
and in contrast, these non-epithelial cells at the same loca-
lizations seemed to be negative for E-and N-cadherin.
Canalicular period (weeks 16 to 28)
E-cadherin was strongly expressed in the epithelial cells
of bronchi and bronchioles and also in the pretype II
cells of developing alveoli (Figure 2A, 2B). N-cadherin
was faintly or moderately expressed in the cells of
bronchi and bronchioles whereas the cells of developing
alveoli were negative (Figure 2C, 2D). b-catenin was
strongly membrane-bound positive in the cells of
bronchi and bronchioles, whereas the cells of alveoli
showed mainly nuclear-type of positivity especially at
the beginning of the stage (Figure 2E, 2F, 2G). However,
at the end of this period, the amount of membrane-
bound positivity within alveolar epithelium increased,
and correspondingly, the nuclear positivity decreased.
Saccular (weeks 28 to 36) period
E-cadherin was expressed strongly in the epithelial cells
of bronchi and bronchioles with its expression being
clearly positive within alveoli in type II cells (Figure 3A,
3B). N-cadherin was positive in some of the epithelial
cells in bronchi and bronchioles, but its expression in
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Page 3 of 14Figure 1 Immunohistochemical stainings for E- and N-cadherin and b-catenin during pseudoglandular period of developing human
lung. 1A and 1B. Epithelium of the developing airways is positive for E-cadherin (arrows). 1C and 1 D. Epithelium of some developing airways is
positive for N-cadherin (arrows) whereas other developing airways are negative for N-cadherin (short arrows). 1E and 1F. Epithelial and
mesenchymal cells of developing airways are positive for b-catenin. In most airways epithelial cells display nuclear positivity (arrows) whereas
some airways exhibit membrane-bound positivity (short arrows). 1G. A high power field image showing nuclear positivity for b-catenin in
epithelial cells of a small developing airway (arrows) surrounded by positively stained mesenchymal cells (short arrows). 1 H. A negative control
in which the primary antibody has been substituted with non-immune serum. Arrows are indicating developing airways. Scale bars = 40 μmi n
1A, 1C, 1F and 1H; scale bars = 20 μm in 1B, 1 D and 1G, and scale bar = 80 μm in 1E.
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Page 4 of 14Figure 2 Immunohistochemical stainings for E- and N-cadherin and b-catenin during canalicular period of developing human lung.
2A and 2B. Epithelial cells of a developing bronchiolus (short arrows) and alveoli including pretype II pneumocytes (arrows) are positive for
E-cadherin. 2C. Pretype II pneumocytes (short arrows) of alveoli are negative for N-cadherin while epithelial cells of a bronchiolus (arrow) are
positive for N-cadherin. 2 D. In addition of the epithelial cells (arrows), some spindle shaped cells of a bronchiole showed also a positivity for
N-cadherin (short arrow). 2E, 2F and 2G. Epithelial cells of developing airways including pretype II pneumocytes are positive for b-catenin
showing mostly a nuclear positivity (arrows) and also a membrane-bound positivity in some cells (short arrows). 1 H. A negative control in which
the primary antibody has been substituted with non-immune serum. Scale bars = 40 μm in 2A, 2C, 2E and 2 H; scale bars = 20 μm in 2B, 2D, 2F
and 2G.
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Page 5 of 14Figure 3 Immunohistochemical stainings for E- and N-cadherin and b-catenin during saccular period of developing human lung.
3A and 3B. A strong positivity for E-cadherin is seen in the epithelial cells of a bronchiole (arrows) and type II pneumocytes of alveoli are also
positive for E-cadherin (short arrows). 3C. Alveolar epithelium is negative for N-cadherin (arrows). 3 D. A few epithelial cells of a bronchiole are
positive for N-cadherin (arrows). 3E and 3F. Positive staining for b-catenin is seen in the epithelial cells of a bronchiole (arrows) and alveolar
epithelial cells (short arrows). 3G. A high power field image showing a positive expression for b-catenin within alveoli. Some alveolar epithelial
cells exhibit nuclear staining (arrows). 3 H. A negative control in which the primary antibody has been substituted with non-immune serum.
Scale bars = 40 μm in 3A, 3C, 3E and 3H; scale bars = 20 μm in 3B, 3D, 3F and 3G.
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Page 6 of 14alveoli remained negative (Figure 3C, 3D). b-catenin
revealed membrane-bound positivity in the cells of
bronchi and bronchioles, and the cells of alveolar
epithelium were also mainly membrane-type positive,
although some alveolar epithelial cells exhibited also
nuclear-type positivity (Figure 3E, 3F, 3G).
Alveolar (weeks 36 to 40) period
E-cadherin was moderately positive in the epithelium of
bronchi and bronchioles and in type II pneumocytes
w i t h i na l v e o l i( F i g u r e4 A ,4 B ) .N - c a d h e r i nw a sf a i n t l y
expressed in only a few scattered cells of the epithelium
of bronchi and bronchioles. Most of the bronchial
Figure 4 Immunohistochemical stainings for E- and N-cadherin and b-catenin during alveolar period of developing human lung.
4A and 4B. Type II pneumocytes (short arrows) and bronchial epithelial cells (arrows) display a positive staining for E-cadherin. 4C. Alveoli do not
show any positivity for N-cadherin. 4 D. Type II pneumocytes of alveoli (arrows) are strongly positive for b-catenin. 4F. An example of vimentin
staining showing that alveoli are positive for it. 4G. A negative control in which the primary antibody has been substituted with non-immune
serum. 4 H. A negative control in which the primary antibody has been substituted with PBS with haematoxylin counterstain. Scale bars =
40 μm in 4A, 4C and 4D; scale bars = 20 μm in 4B, 4E, 4F, 4G and 4 H.
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Page 7 of 14epithelial cells were negative for N-cadherin, nor could
it be detected in the alveoli (Figure 4C). b-catenin
revealed strong membrane-bound positivity in the cells
of bronchi and bronchioles, and the cells of alveolar
epithelium were also mainly membrane-type positive,
although some alveolar epithelial cells showed also
nuclear-type positivity (Figure 4D, 4E).
Mesothelium, fibroblasts, myofibroblasts, smooth mus-
cle cells and endothelium were positive for b-catenin,
but negative for E- and N-cadherin. The neural cells dis-
played positivity for N-cadherin. In some cases during
the pseudoglandular period, trachea was included within
the tissue sample, and its epithelium was positive for E-
and N-cadherin and b-catenin. Negative controls
obtained by substituting non-immune rabbit or mouse
serum and PBS for the primary antibodies showed no
positive staining (Figure 1H, 2H, 3H, 4G, 4H).
The results of the scoring of the immunoreactivity for
various proteins are shown in Table 1. One score shown
for each protein in various periods is valid for every
case analyzed. If the samples of the same developmental
stage showed variable staining with each other, two
scores are shown.
Normal adult lung as a control
E-cadherin was expressed in most epithelial cells of nor-
mal adult human lung including type II pneumocytes and
also in all bronchial epithelial cells whereas mesothelial
cells remained negative (Figure 5A). Alveolar epithelial
cells including both type I and II pneumocytes were nega-
tive for N-cadherin (Figure 5B), while mesothelial cells
Table 1 Immunoreactivity scores for E- and N-cadherin, b-catenin, TTF-1 and caveolin-1 in different types of
pulmonary cells in developing human lung during various gestational periods.
Pseudo-glandular period
day 52-week 16
(13 cases)
Canalicular period
weeks 16-28
(17 cases)
Saccular period
weeks 28-36
(9 cases)
Alveolar period
weeks 36-40
(8 cases)
E-cadherin
bronchus +++ +++ +++ ++
bronchiolus +++ +++ +++ ++
alveolus # + * + or ++ # + # +
endothelial cell negative negative negative negative
stromal cells negative negative negative negative
N-cadherin
bronchus ++ ++ + (+)
bronchiolus + or ++ ++ + (+)
alveolus # negative or + negative negative negative
endothelial cell negative negative negative negative
stromal cells negative negative negative negative
b-catenin
bronchus +++ m +++ m +++ m +++ m
bronchiolus +++ m +++ m +++ m +++ m
alveolus # +++ n * +++ n and m #++ m and (n) # ++ m and (n)
endothelial cell + + + +
stromal cells +++ n + n negative negative
TTF-1
bronchus + + + +
bronchiolus ++ + or ++ + +
alveolus # +++ * +++ # + # +
endothelial cell negative negative negative negative
stromal cells negative negative negative negative
Caveolin-1
bronchus negative negative negative negative
bronchiolus negative negative negative negative
alveolus negative negative +++ +++
endothelial cel + + + +
stromal cells + + + +
# small developing airways, not alveoli: * pretype II cells: # type II pneumocytes
m = membrane-bound positivity; n = nuclear positivity
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Page 8 of 14and some scattered basal cells of bronchioles were posi-
tive. b-catenin was expressed in type II pneumocytes and
epithelium of bronchioles and also faintly in type I pneu-
mocytes (Figure 5C, 5D). Endothelial cells, some mesench-
ymal cells, and mesothelium stained also positively for
b-catenin. The staining pattern for b-catenin was mainly
membranous, but some type II pneumocytes exhibited
cytoplasmic expression pattern for b-catenin with nuclear
enhancement. Type II pneumocytes and some epithelial
cells of bronchioles showed a positive staining for TTF-1
(Figure 5E). Cells lining alveoli expressed positively for
caveolin-1 (Figure 5F).
Figure 5 Immunohistochemical stainings for E- and N-cadherin, b-catenin, TTF-1 and caveolin-1 in adult human lung.5 A .T y p eI I
pneumocytes of alveoli are positive for E-cadherin (arrows). 5B. Epithelial cells of a bronchiole are expressing E-cadherin (arrows). 5C. Cells of
alveoli are negative for N-cadherin (arrows). 5 D. Type II pneumocytes (arrows) and to a lesser extent also type I pneumocytes of alveoli are
positive for b-catenin. 5E. Epithelial cells of a bronchiole are positive for b-catenin. 5F. Type II pneumocytes exhibit a positive staining for TTF-1
(arrows). 5G. A staining of caveolin-1 is positive in alveolar epithelium (arrows). 5G. A negative control in which the primary antibody has been
substituted with non-immune serum. Scale bars = 20 μm.
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Page 9 of 14Figure 6 Immunohistochemical stainings for TTF-1 and caveolin-1 during pseudoglandular, canalicular, saccular and alveolar periods
of developing human lung. 6A. Epithelial cells of small developing airways during pseudoglandular period are strongly positive for TTF-1
(arrows). 6B. Epithelial cells of a developing airway during pseudoglandular period are negative for caveolin-1 (arrow) while the cells surrounding
the airway (short arrow) and obvious endothelial cells (arrowheads) are positive for it. 6C. Pretype II cells during the canalicular period are
positive for TTF-1 (arrows). 6 D. Pretype II cells during the canalicular period do not show any positivity for caveolin-1 (arrows) while the cells
rounding alveoli (short arrows) as well as the endothelial cells (arrowheads) are positively stained. 6E and 6G. Type II pneumocytes are positive
for TTF-1 during saccular (6E) and alveolar (6G) periods (arrows). 6F and 6H. Caveolin-1 is positive during saccular (6F) and alveolar (6H) periods
in alveolar epithelial cells (arrows) whereas bronchial epithelial cells do not exhibit any posivity (short arrows). Scale bars = 20 μm.
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Page 10 of 14Immunohistochemistry for TTF-1 and caveolin-1
Pseudoglandular period (weeks 12 to 16)
TTF-1 was expressed in all epithelial cells of developing
airways (Figure 6A) while caveolin-1 was negative in air-
way epithelial cells but positive in stromal and endothe-
lial cells (Figure 6B).
Canalicular period (weeks 16 to 28)
TTF-1 was faintly positive in occasional cells of bronchi
while its expression was stronger especially in epithelial
cells of terminal and respiratory bronchioles. TTF-1 was
strongly expressed in alveolar epithelium i.e. in pretype
II cells (Figure 6C). As in pseudoglandular period,
caveolin-1 was negative in epithelial cells of alveoli and
bronchioles but positive in stromal and endothelial cells
(Figure 6D).
Saccular (weeks 28 to 36) period
TTF-1 was expressed in scattered epithelial cells of
bronchi and bronchioles and it was clearly positive in
alveoli in type II pneumocytes (Figure 6E). Caveolin-1
was positive in alveolar epithelial cells whereas bronchial
epithelial cells did not exhibit any positivity (Figure 6F).
Stromal and endothelial cells were also positive for
caveolin-1.
Alveolar (weeks 36 to 40) period
TTF-1 was positive in scattered epithelial cells of
bronchi and bronchioles and in alveolar type II pneumo-
cytes (Figure 6G). Caveolin-1 staining was positive in
alveolar epithelial, stromal and endothelial cells, but not
in bronchial epithelium (Figure 6H).
RT-PCR
Total RNA was isolated from paraffin embedded tissues
and converted into cDNA for quantitative PCR analysis
of E- and N-cadherin and b-catenin. First, the quality of
synthesized cDNA was confirmed by GAPDH analysis.
Due to the low expression of GAPDH, two samples from
developing lung were excluded from the further analysis
leaving 3 samples from the pseudoglandular period, 8
from canalicular, 7 from saccular and 3 from alveolar
period. The analysis of the examined samples revealed
that the relative expression of GAPDH was 1.02-fold (SD
0.15) during the pseudoglandular period, 1.17-fold (SD
0.31) during canalicular, 1.14-fold (SD 0.19) during sac-
cular and 1.36-fold (SD 0.27) during the alveolar period
compared to average adult lung. Since these differences
were minor, GAPDH was considered as a house-keeping
gene and used as the denominator in the quantification
of E- and N-cadherin and b-catenin by RT-PCR.
E- and N-cadherin and b-catenin were all very highly
expressed during the pseudoglandular period and their
expression declined towards maturation (Figure 7).
E-cadherin expression was 5.9-fold (SD 3.2) during the
pseudoglandular period, 3.7-fold (SD 2.1) during cana-
licular, 3.4-fold (SD 2.1) during saccular and 2.1-fold
during alveolar period as compared to average adult
lung. N-cadherin was even more extensively upregu-
lated, showing 32 (SD 18), 20 (SD 17), 12 (SD 6.6) and
5.6 (SD 3.9) times more expression than adult lung
during the various developmental periods. b-catenin
expression was 8.8-fold (SD 4.3) during pseudoglandu-
lar, 6.4-fold (SD 3.9) during canalicular, 5.5-fold (SD
2.4) during saccular and 3.8-fold (SD 1.9) during alveo-
lar period compared to adult lung. However, as
revealed by the the standard deviations, there was
extensive variation between the samples in all analyzes
and therefore the differences between the groups do
not achieve statistical significance but the expression
of both E- and N-cadherin and b-catenin in the devel-
oping lung differed significantly from the adult lung
(p < 0,001).
Figure 7 Quantitative RT-PCR analysis of E-cadherin (A), N-cadherin (B) and b-catenin (C). The RNA was isolated from paraffin embedded
tissue samples of pseudoglandular (n = 3), canalicular (n = 8), saccular (n = 7) and alveolar (n = 3) periods and from adult lung (n = 5). The
isolated RNA was reverse transcribed into cDNA before real-time PCR. The results were analysed against the GAPDH expression to give relative
expression values and related to one adult lung sample. One asterisk represents the probability value below 0.05 and two asterisks values below
0.01 compared to healthy control group.
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Page 11 of 14Discussion and Conclusions
The present study describes for the first time the immu-
nohistochemical expression of E- and N-cadherin and
b-catenin at the tissue level during human lung develop-
ment at different gestational ages i.e. from week 12 to
week 40 during the pseudoglandular, canalicular, saccu-
lar and alveolar periods. As anticipated, E-cadherin was
found to be expressed throughout the various periods in
both bronchiolar and alveolar epithelium. The expres-
sion of N-cadherin was also seen in epithelial cells of
developing airways during all developmental stages,
being at its strongest in the pseudoglandular and canali-
cular periods, though it remained positive in some scat-
tered bronchial epithelial cells in later gestation i.e.
during the saccular and alveolar periods. This finding
was somewhat unexpected since traditionally N-cadherin
has been assumed to be a marker of neural and
mesenchymal cells. We have previously observed similar
expression variability of several tight junctional proteins,
namely claudins, in developing human lung [15]. b-
catenin was widely expressed throughout all periods in
various types of pulmonary cells including both epithe-
lial, endothelial and mesenchymal cells, a not unex-
pected finding when taking into consideration its diverse
roles in controlling cell biological functions and lung
development. Not only the cell-specific localizations of
b-catenin varied within lung tissue, but also its distribu-
tion within the cell i.e. during early lung development
b-catenin was expressed mostly as nuclear type positiv-
ity within epithelial cells and also in cells underneath
the epithelia of airways, whereas it was expressed mainly
as epithelial membrane-bound positivity during mid-
and late-gestation. In addition, immunohistochemical
and RT-PCR findings of the developing lung were com-
pared to that of the normal adult human lung. By both
methods used, the expressions of N- and E-cadherin
and b-catenin were shown to be higher during the lung
development than in the adult lung.
In rat lung, it has been reported that all epithelial cells
of the lung express both E- and P-cadherin during the
early developmental stage whereas P-cadherin gradually
disappears during development, initially from the main
bronchi but eventually from all epithelial cells [19]. In
the study of Kasper et al., localization of E-cadherin was
examined in fetal human lung and it was noted that the
epithelia of primary pulmonary primordium and the sec-
ondary bronchi were positive for E-cadherin with the
immunoperoxidase and immunofluorescence techniques
[20]. As far as we are aware there are no previous pub-
lished studies on the immunohistochemical expression
of E-cadherin in developing human lung which have
investigated several gestational stages. The role of E-
cadherin in the invasiveness of lung cancers and also its
role as a commonly used epithelial cell marker in EMT-
studies has attracted more attention in the previous
studies [21,22]. In the present study we observed that
in general E-cadherin was strongly expressed in the
epithelia of bronchi and bronchioles from week 12 to
week 40. It was also expressed in all epithelia of devel-
oping alveoli during the canalicular period when the
cells that lines the alveoli are so called pretype II cells,
which will subsequetly differentiate into type I and type
II pneumocytes from weeks 24-28 onwards. E-cadherin
was also clearly positive in type II pneumocytes during
the saccular and alveolar periods, but its expression in
type I pneumocytes was not clearly positive.
For identifying the phenotype of alveolar epithelial
cells, we performed immunohistochemical stainings of
our study material also for TTF-1 and caveolin-1. TTF-
1 is known to be present in type II pneumocytes and
also in subsets of bronchiolar cells, and moreover, the
distribution of TTF-1 has been shown to follow patterns
of distribution of surfactant protein-B in developing and
diseased lungs [23,24]. TTF-1 has been detected in
epithelial cells of human fetal lung as early as during the
11-12 weeks’ gestation, a finding similar to ours [24].
Caveolins are the structural proteins that are necessary
for the formation of caveolae membrane domains, and
they are expressed in several types of organs and cells
including type I pneumocytes [25]. In our study, E-
cadherin was shown to be co-expressed with TTF-1
during various gestational ages. The positive expression
for b-catenin was seen in cells that were positive either
for TTF-1 or caveolin-1. During early gestation i.e. in
pseudoglandular and canalicular periods N-cadherin was
expressed in cells that seemed to be positive also for
TTF-1.
T h e r ei sl i t t l ek n o w na b o u tN - c a d h e r i ne x p r e s s i o ni n
the developing lung. Packer and colleagues evaluated
the mRNA of N-cadherin in several mouse organs, and
observed its expression in mesenchymal, but not in
epithelial cells of lung [9]. N-cadherin has been assumed
to be mainly expressed in mesenchymal cells, and thus
has been considered as a marker of EMT, a structure
postulated have a marked role also in the pathogenesis
of lung cancers [26]. In our previous study, we observed
that N-cadherin was expressed in a certain types of lung
cancers such as endocrine tumors including small cell
carcinomas and also in epithelial tumors like squamous
cell carcinomas which are believed to originate from the
bronchial epithelium [11]. We did not find any positivity
for N-cadherin in normal or metaplastic bronchial
epithelium in that particular study. In the present study,
however, N-cadherin was clearly positive in the epithelia
of developing bronchi and bronchioles during the early
and mid gestation periods i.e. in the pseudo-glandular
and canalicular periods, and it remained positive in
some scattered bronchial cells also in later gestation i.e.
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even pretype II cells, did not show any positivity for
N-cadherin. The finding of the epithelial expression of
N-cadherin during normal human lung development has
two important implications. First N-cadherin might not
be the most suitable marker for studying EMT, and sec-
ondly malignant cells may acquire the properties of fetal
cells as indicated in the findings of the previous lung
cancer studies.
b-catenin and the Wnt/b-catenin signaling pathway
regulate certain aspects of branching morphogenesis,
regional specialization of the epithelium and mesench-
yme [13]. In an experimental study with mice, it was
found that when the gene for b-catenin was excised in
epithelial cells prior to embryonic day 14.5, the proximal
lung tubules grew and differentiated normally, but the
mice eventually succumbed due to respiratory failure
[14]. This study also revealed that b-catenin staining in
control animals as visualized by immunohistochemistry
was present both as membrane-bound and also as
nuclear positivity. These workers did not find nuclear
staining in larger airways, when it was most prominent
in epithelial cells lining the more peripheral tubules. We
also observed that the immunohistochemical staining
appeared mainly as two types; nuclear and membrane-
bound. During early gestation i.e. in the pseudoglandular
period, b-catenin expression in the epithelia of the smal-
lest developing airways was mostly intensely nuclear,
and also the mesenchymal cells beneath the airway
epithelia displayed nuclear positivity. The epithelia of
bronchi and largest bronchioles showed mainly mem-
brane-bound positivity for b-catenin throughout all
gestational periods. At the beginning of the canalicular
period, the nuclear staining for b-catenin still existed,
but it had eventually disappeared by the end of that per-
iod. b-catenin was also positive in pretype II cells and
type II pneumocytes of alveoli, and also in endothelial
and mesothelial cells. The results of our study support
the results of the previous studies underlining the
importance of b-catenin in the organogenesis of lung.
We concluded that E-cadherin was widely expressed
in bronchial and alveolar epithelial cells throughout all
developmental periods whereas N-cadherin showed
epithelial positivity in bronchial epithelial cells mainly
during the early developmental stages of lung. Thus it
may be assumed that E-cadherin is relatively constantly
present through ontogenesis of human lung whereas
N-cadherin seems to be more restricted to certain devel-
opmental phases. The presence of b-catenin was
observed in several cell types with distinct location in
tissues and cells of various gestational stages indicating
that this protein possesses several roles during lung
development. The overall expression of the proteins and
mRNAs of E- and N-cadherin and b-catenin were,
however, higher in early compared to the situation in
the later phases of gestation. Moreover, the expressions
of these factors were higher during the lung develop-
ment than in the adult human lung.
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